Nuzenio

Advanced Therapy Designation

Advanced Therapy Designation news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 11 publisher sources 100/100 entity strength

Latest news

FDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - OncodailyOncodaily · Wed, 05 Aug 2026 13:26:29 GMTLexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 11:00:00 GMTLexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For LX2020 For The Treatment Of PKP2 Arrhythmogenic Cardiomyopathy - marketscreener.commarketscreener.com · Wed, 05 Aug 2026 11:00:00 GMTFDA Grants RMAT Designation to Sasineprocel for Parkinson Disease - NeurologyLiveNeurologyLive · Tue, 04 Aug 2026 22:35:24 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -Pharmaceutical Business review - · Tue, 04 Aug 2026 19:15:28 GMTFDA backs faster development path for Parkinson’s cell therapy - Parkinson's News TodayParkinson's News Today · Mon, 03 Aug 2026 22:15:42 GMTLilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer - PR NewswirePR Newswire · Mon, 03 Aug 2026 11:45:00 GMTClearPoint Neuro Congratulates Partner Aspen Neuroscience on FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Sasineprocel - ACCESS NewswireACCESS Newswire · Fri, 31 Jul 2026 20:07:34 GMT

Timeline

Wed, 05 Aug 2026 13:26:29 GMTFDA Grants Breakthrough Therapy Designation to Olomorasib for KRAS G12C-Mutant Advanced Pancreatic Cancer - Oncodaily
Wed, 05 Aug 2026 11:00:00 GMTLexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for LX2020 for the Treatment of PKP2 Arrhythmogenic Cardiomyopathy - Yahoo Finance
Wed, 05 Aug 2026 11:00:00 GMTLexeo Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation For LX2020 For The Treatment Of PKP2 Arrhythmogenic Cardiomyopathy - marketscreener.com
Tue, 04 Aug 2026 22:35:24 GMTFDA Grants RMAT Designation to Sasineprocel for Parkinson Disease - NeurologyLive
Tue, 04 Aug 2026 19:15:28 GMTFDA grants breakthrough therapy designation to Lilly’s olomorasib - Pharmaceutical Business review -
Mon, 03 Aug 2026 22:15:42 GMTFDA backs faster development path for Parkinson’s cell therapy - Parkinson's News Today

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Advanced Therapy Designation.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.